Enter Your Information Below To Receive Free Trading Ideas, Latest News and Articles

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
    Popular Topics

    RAD 202 receives approval to start Phase 1 therapeutic trial

    Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

    Download the PDF here.

    This post appeared first on investingnews.com